UB Paderborn / Katalog / Suche / in CDI

Transdermal hormone therapy and the risk of stroke and venous thrombosis

Climacteric : the journal of the International Menopause Society, 2010-10, Vol.13 (5), p.429-432

Speroff, L.

2010

Volltextzugriff (PDF)

Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group

Maturitas, 2005-05, Vol.51 (1), p.21

2005

Volltextzugriff (PDF)

Low-dose hormone therapy in postmenopausal women in China

Climacteric : the journal of the International Menopause Society, 2010-12, Vol.13 (6), p.544-552

2010

Volltextzugriff (PDF)

Endometrial cancer—Surprising reports

Maturitas, 2005-08, Vol.51 (4), p.329-333

Speroff, L.

2005

Volltextzugriff (PDF)

The meaning of mammographic breast density in users of postmenopausal hormone therapy

Maturitas, 2002-03, Vol.41 (3), p.171-175

Speroff, Leon

2002

Volltextzugriff (PDF)

I170 E2V/DNG: contraceptive efficacy and safety data

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S42-S42

2009

Volltextzugriff (PDF)

HEALTH BENEFITS OF ORAL CONTRACEPTIVES

Obstetrics and gynecology clinics of North America, 2000-12, Vol.27 (4), p.705-721

2000

Volltextzugriff (PDF)

Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms

Obstetrics and gynecology (New York. 1953), 2003-10, Vol.102 (4), p.823-834

Speroff, Leon

2003

Volltextzugriff (PDF)

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

Fertility and sterility, 2001-07, Vol.76 (1), p.25-31

2001

Volltextzugriff (PDF)

Postmenopausal hormone therapy and the risk of breast cancer

Maturitas, 1999-08, Vol.32 (3), p.123-129

SPEROFF, L

1999

Volltextzugriff (PDF)

A clinician's response to the oral contraceptive thrombosis controversy

Human reproduction update, 1999-11, Vol.5 (6), p.654

Speroff, L

1999

Volltextzugriff (PDF)

Postmenopausal hormone therapy and primary prevention of cardiovascular disease — Nurses’ health study 20-year follow-up

Maturitas, 2001-05, Vol.38 (3), p.221-224

Speroff, L

2001

Volltextzugriff (PDF)

The postpartum visit: it's time for a change in order to optimally initiate contraception

Contraception (Stoneham), 2008-08, Vol.78 (2), p.90-98

2008

Volltextzugriff (PDF)

The Million Women Study and breast cancer

Maturitas, 2003-09, Vol.46 (1), p.1-6

Speroff, Leon

2003

Volltextzugriff (PDF)

It's time to stop using the word 'replacement'

Maturitas, 2000-01, Vol.34 (1), p.1-3

Speroff, L

2000

Volltextzugriff (PDF)

Marked changes in the circulating levels and ratios of angiopoietins during pregnancy, compared to natural menstrual cycles and controlled ovarian stimulation

Fertility and sterility, 2007, Vol.88, p.S69-S70

2007

Volltextzugriff (PDF)

Oral contraceptives and arterial and venous thrombosis: A clinician’s formulation

American journal of obstetrics and gynecology, 1998-07, Vol.179 (1), p.S25-S36

Speroff, Leon

1998

Volltextzugriff (PDF)

The Heart and Estrogen/progestin Replacement Study (HERS)

Maturitas, 1998-11, Vol.31 (1), p.9-14

Speroff, Leon

1998

Volltextzugriff (PDF)

Tibolone: Clinical recommendations and practical guidelines

Maturitas, 2005-05, Vol.51 (1), p.21-28

2005

Volltextzugriff (PDF)

Mircette: a novel oral contraceptive. Introduction

American journal of obstetrics and gynecology, 1998-07, Vol.179 (1), p.S1

Speroff, L

1998

Volltextzugriff (PDF)

Evaluation of a new generation of oral contraceptives

Obstetrics and gynecology (New York. 1953), 1993-06, Vol.81 (6), p.1034-1047

1993

Volltextzugriff (PDF)

Postmenopausal hormone therapy into the 21st century

International journal of gynaecology and obstetrics, 1997-10, Vol.59 (S1), p.S3-S10

Speroff, L.

1997

Volltextzugriff (PDF)

Practical guidelines for postmenopausal hormone therapy

Maturitas, 2005-05, Vol.51 (1), p.4-7

2005

Volltextzugriff (PDF)

The effect of aging on fertility

Current opinion in obstetrics & gynecology, 1994-04, Vol.6 (2), p.115-120

Speroff, L

1994

Volltextzugriff (PDF)

Oral contraceptives and venous thromboembolism

International journal of gynecology and obstetrics, 1996-07, Vol.54 (1), p.45-50

Speroff, L.

1996

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Transdermal hormone therapy and the risk of stroke and venous thrombosis

Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group

Low-dose hormone therapy in postmenopausal women in China

Endometrial cancer—Surprising reports

The meaning of mammographic breast density in users of postmenopausal hormone therapy

I170 E2V/DNG: contraceptive efficacy and safety data

HEALTH BENEFITS OF ORAL CONTRACEPTIVES

Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

Postmenopausal hormone therapy and the risk of breast cancer

A clinician's response to the oral contraceptive thrombosis controversy

Postmenopausal hormone therapy and primary prevention of cardiovascular disease — Nurses’ health study 20-year follow-up

The postpartum visit: it's time for a change in order to optimally initiate contraception

The Million Women Study and breast cancer

It's time to stop using the word 'replacement'

Marked changes in the circulating levels and ratios of angiopoietins during pregnancy, compared to natural menstrual cycles and controlled ovarian stimulation

Oral contraceptives and arterial and venous thrombosis: A clinician’s formulation

The Heart and Estrogen/progestin Replacement Study (HERS)

Tibolone: Clinical recommendations and practical guidelines

Mircette: a novel oral contraceptive. Introduction

Evaluation of a new generation of oral contraceptives

Postmenopausal hormone therapy into the 21st century

Practical guidelines for postmenopausal hormone therapy

The effect of aging on fertility

Oral contraceptives and venous thromboembolism

Suchergebnisse filtern